Reuters logo
BRIEF-Velicept reports FDA acceptance of IND application for overactive bladder treatment
October 5, 2016 / 11:22 AM / a year ago

BRIEF-Velicept reports FDA acceptance of IND application for overactive bladder treatment

Oct 5 (Reuters) - Velicept Therapeutics:

* Announces FDA Acceptance Of IND Application Of novel, once- daily formulation of Solabegron for the treatment of overactive bladder Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below